RPS6KB1 and neoplasm: In vitro experiments confirmed that CCDC138 knockdown significantly reduced mTOR (69% reduction) and S6K1 (54% reduction) mRNA expression, validating the bioinformatics association with the mTOR pathway and suggesting that CCDC138 directly or indirectly modulates this pathway to promote tumor growth.